PAS
ONC

Point72 Asia (Singapore)’s BeOne Medicines Ltd ONC Stock Holding History

Point72 Asia (Singapore)’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-179
Closed -$48.8K – 1319
2025
Q1 		$48.8K Sell
179
-512
-74% -$120K 0.01% 575
2024
Q4 		$128K Buy
691
+391
+130% +$79.9K 0.03% 316
2024
Q3 		$67.3K Buy
+300
New +$54K 0.01% 634
2018
Q3 		– Sell
-8,521
Closed -$1.31M – 12
2018
Q2 		$1.31M Buy
8,521
+2,599
+44% +$464K 17.08% 3
2018
Q1 		$995K Buy
+5,922
New +$802K 19.4% 2

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asia (Singapore)'s ONC Position: Q2 2025 in Review

Point72 Asia (Singapore) sold out of BeOne Medicines Ltd (ONC) in Q2 2025, closing a stake of 179 shares — an estimated $48.8K sold.

Point72 Asia (Singapore) first reported a position in ONC in Q1 2018 and held it in 5 quarters. The position peaked at $1.31M in Q2 2018. 243 funds tracked by Wall St. Rank hold ONC as of Q2 2025.

  • Point72 Asia (Singapore) reported no remaining BeOne Medicines Ltd position as of Q2 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 179 BeOne Medicines Ltd shares in Q2 2025, an estimated $48.8K.
  • Point72 Asia (Singapore) first reported a position in BeOne Medicines Ltd in Q1 2018 and held it in 5 quarters.
  • Point72 Asia (Singapore)'s BeOne Medicines Ltd position peaked at $1.31M in Q2 2018.
  • 243 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q2 2025, filed 14 Aug 2025.